Leishmaniasis among organ transplant recipients

The Lancet Infectious Diseases - Tập 8 - Trang 191-199 - 2008
Spinello Antinori1, Antonio Cascio2, Carlo Parravicini1, Roberto Bianchi3, Mario Corbellino1
1Department of Clinical Sciences L Sacco, Section of Infectious Diseases and Immunopathology, University of Milan, Milan, Italy
2Department of Human Pathology, Institute of Infectious Diseases, University of Messina, Messina, Italy
3Division of Otorhinolaryngology, IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Tài liệu tham khảo

Desjeux, 2001, The increase in risk factors for leishmaniasis worldwide, Trans R Soc Trop Med Hyg, 95, 239, 10.1016/S0035-9203(01)90223-8 Cohen, 1991, Leishmaniasis acquired in Belgium, Lancet, 338, 128, 10.1016/0140-6736(91)90129-D Singh, 1996, Transfusion-transmitted kala-azar in India, Transfusion, 36, 848, 10.1046/j.1537-2995.1996.36996420769.x Kubar, 1997, Transmission of Leishmania infantum by blood donors, Nat Med, 3, 368, 10.1038/nm0497-368 Le Fichoux, 1999, Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity of southern France, J Clin Microbiol, 37, 1953, 10.1128/JCM.37.6.1953-1957.1999 Cruz, 2002, Leishmania in discarded syringes from intravenous drug users, Lancet, 359, 1124, 10.1016/S0140-6736(02)08160-6 Desieux, 1992, Human leishmaniases: epidemiology and public health aspects, World Health Stat Q, 45, 267 Badarò, 1996, New perspectives on a subclinical form of visceral leishmaniasis, J Infect Dis, 154, 1003, 10.1093/infdis/154.6.1003 Desieux, 2002, Leishmania/HIV coinfection: epidemiology in Europe, Ann Trop Med Parasitol, 97, S3 Pintado, 2001, Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients, Medicine, 80, 54, 10.1097/00005792-200101000-00006 Ma, 1979, Fatal leishmaniasis in renal transplant patient, Lancet, 2, 311, 10.1016/S0140-6736(79)90333-7 Patel, 1997, Infections in solid-organ transplant recipients, Clin Microbiol Rev, 10, 86, 10.1128/CMR.10.1.86 Broeckaert-Van Orshoven, 1979, Fatal leishmaniasis in renal transplant patient, Lancet, 2, 740, 10.1016/S0140-6736(79)90664-0 Aguado, 1986, Visceral leishmaniasis in renal transplant recipient: a diagnostic and therapeutic challenge, J Infect, 13, 301, 10.1016/S0163-4453(86)91553-7 Salva, 1986, Visceral leishmaniasis in kidney transplantation: report of one case, Clin Transplant, 1, 134 Lamas, 1987, Non-fatal leishmaniasis in a renal transplant recipient, Nephron, 45, 71, 10.1159/000184076 Le Cacheux, 1990, Visceral leishmaniasis of favourable course in a patient with renal transplantation, Rev Med Intern, 11, 250, 10.1016/S0248-8663(10)80013-X Donovan, 1990, Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient, J Infect, 21, 107, 10.1016/0163-4453(90)90830-2 Rousaud, 1991, Primary visceral leishmaniasis in a renal transplanted patient, Nefrologia, 11, 72 Kher, 1991, Visceral leishmaniasis: an unusual case of fever in a renal transplant recipients, Nephrol Dial Transplant, 6, 736, 10.1093/ndt/6.10.736 Moulin, 1992, Leishmaniasis: a rare case of unexplained fever in a renal graft recipient, Nephron, 60, 360, 10.1159/000186779 Orofino, 1992, Visceral leishmaniasis in renal transplant patients, Nephron Dial Transplant, 7, 71, 10.1093/ndt/7.7.651 Jopikii, 1992, Leishmaniasis diagnosed from bronchoalveolar lavage, Scand J Infect Dis, 24, 677, 10.3109/00365549209054657 Golino, 1992, Leishmaniasis in a heart transplant patient, J Heart Lung Transplant, 11, 820 Dunan, 1993, Four observations of visceral leishmaniasis following kidney transplantation. Pathogenetic and therapeutic considerations, Med Mal Infect, 23, 297, 10.1016/S0399-077X(05)80548-7 Horber, 1993, Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly, Transpl Int, 6, 55, 10.1111/j.1432-2277.1993.tb00747.x Torregrosa, 1993, Visceral leishmaniasis-like cause of unexplained fever in a reno-pancreatic graft recipient, Nephron, 65, 318, 10.1159/000187498 Halim, 1993, Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate, Clin Infect Dis, 16, 397, 10.1093/clind/16.3.397 Venencie, 1993, Disseminated cutaneous leishmaniasis in a case of an immunodepressed woman, Ann Dermatol Venereol, 120, 461 Moroni, 1995, Don't forget visceral leishmaniasis in transplant patients, Nephrol Dial Transplant, 10, 563, 10.1093/ndt/10.4.563 Hosseini, 1995, A case report of kala-azar in a kidney transplant patient, Transplant Proc, 27, 2715 Mittal, 1995, Visceral leishmaniasis: a rare cause of unexplained pyrexia in a renal allograft recipient, Nephron, 70, 123, 10.1159/000188563 Sharma, 1996, Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems, Am J Nephrol, 16, 358, 10.1159/000169024 Torrus, 1996, Meglumine antimoniate-induced pancreatitis, Am J Gastroenterol, 91, 820 Esteban, 1996, Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure, Nephrol Dial Transplant, 11, 1898, 10.1093/oxfordjournals.ndt.a027706 Apaydin, 1997, Visceral leishmaniasis without fever in a kidney transplant recipient, Nephron, 75, 241, 10.1159/000189541 Gomez-Campedera, 1998, Visceral leishmaniasis in a renal transplant recipient, Am J Nephrol, 18, 171, 10.1159/000013329 Roustan, 1998, Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B, Br J Dermatol, 138, 526, 10.1046/j.1365-2133.1998.02139.x Iborra, 1998, Mucosal leishmaniasis in a heart transplant recipient, Br J Dermatol, 138, 190, 10.1046/j.1365-2133.1998.02051.x Alrajhi, 1998, Leishmaniasis of the tongue in a renal transplant recipient, Clin Infect Dis, 27, 1332, 10.1086/517723 Hueso, 1999, The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate cure with ketoconazole and allopurinol, Nephrol Dial Transplant, 14, 2941, 10.1093/ndt/14.12.2941 Panizo, 2000, First report of visceral leishmaniasis in an orthotopic heart transplant recipient, Transplantation, 69, 1533, 10.1097/00007890-200004150-00061 Llorente, 2000, Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials, Transplantation, 70, 800, 10.1097/00007890-200009150-00016 Hussein, 2001, Non-typhoid salmonella septicemia and visceral leishmaniosis in a renal transplant patient, Transplantation, 71, 479, 10.1097/00007890-200102150-00024 Frapier, 2001, Fatal visceral leishmaniasis in a heart transplant recipient, J Heart Lung Transplant, 20, 912, 10.1016/S1053-2498(01)00263-7 Borgia, 2001, Mucosal leishmaniasis occurring in a renal transplant recipient, Dermatology, 202, 266, 10.1159/000051651 Sabbatini, 2002, Visceral leishmaniasis in renal transplant recipients: is it a challenge to the nephrologist?, Transplantation, 73, 299, 10.1097/00007890-200201270-00026 Fernandes, 2002, Cutaneous leishmaniasis in kidney transplant recipient, Transplant Proc, 34, 504, 10.1016/S0041-1345(02)02611-8 Tavora, 2002, Unusual manifestation of leishmaniasis in renal transplant, Transplant Proc, 34, 502, 10.1016/S0041-1345(02)02610-6 Gontijo, 2002, Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient, Mem Inst Oswaldo Cruz, 97, 751, 10.1590/S0074-02762002000500029 Rajaram, 2002, Visceral leishmaniasis: a rare case of post-transplant fever and pancytopenia, J Assoc Physicians India, 50, 979 Zorio Grima, 2003, Persistent fever, pancytopenia and spleen enlargement in a heart transplant carrier as presentation of visceral leishmaniasis, Rev Clin Esp, 203, 164, 10.1016/S0014-2565(03)71229-6 Morales, 2003, Visceral leishmaniasis in lung transplantation, Transplant Proc, 35, 2001, 10.1016/S0041-1345(03)00664-X Sipsas, 2003, Fever, hepatomegaly and pancytopenia in a renal transplant recipient, Transpl Infect Dis, 5, 47, 10.1034/j.1399-3062.2003.00003.x Ersoy, 2003, A renal transplant recipient with pulmonary tuberculosis and visceral leishmaniasis: review of superimposed infections and therapy approaches, Clin Nephrol, 60, 289, 10.5414/CNP60289 Aliaga, 2003, Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum. Clinical and microbiologic findings in 31 patients, Medicine, 82, 147, 10.1097/01.md.0000076009.64510.b8 Tsiodras, 2004, Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole, Transpl Infect Dis, 9, 37, 10.1111/j.1399-3062.2004.00039.x Halkic, 2004, Recurrent cytomegalovirus disease, visceral leishmaniosis, and legionella pneumonia after liver transplantation: a case report, Can J Anaesth, 51, 84, 10.1007/BF03018554 Sirvent-von Bueltzingsloewen, 2004, Visceral leishmaniasis a new opportunistic infection in hematopoietic stem-cell-transplanted patients, Bone Marrow Transplant, 33, 667, 10.1038/sj.bmt.1704396 Corbellino, 2006, A case of delayed diagnosis of mucocutaneous leishmaniasis in a transplant subject, Giorn It Mal Inf, 12, 222 Mirzabeigi, 2006, Reactivation of dormant cutaneous leishmania infection in a kidney transplant patient, J Cutan Pathol, 33, 701, 10.1111/j.1600-0560.2006.00532.x Portoles, 1994, Visceral leishmaniasis: a cause of opportunistic infection in renal transplant patients in endemic areas, Transplantation, 57, 1677, 10.1097/00007890-199457110-00026 Torrus, 1996, Fluconazole plus allopurinol in treatment of visceral leishmaniasis, J Antimicrob Chemother, 37, 1042, 10.1093/jac/37.5.1042 Berenguer, 1998, Visceral leishmaniasis (kala-azar) in transplant recipients: case report and review, Transplantation, 65, 1401, 10.1097/00007890-199805270-00022 Hernandez-Perez, 1999, Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review, Clin Infect Dis, 29, 918, 10.1086/520457 Bouletis, 1999, Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (Ambisome), Clin Infect Dis, 28, 1308, 10.1086/514784 Rodriguez-Wilhelmi, 2001, Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients, Med Clin, 116, 37 Maggi, 2004, Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician, J Nephrol, 17, 296 Basset, 2005, Visceral leishmaniasis in organ transplant recipients: 11 new cases and review of the literature, Microbes Infect, 7, 1370, 10.1016/j.micinf.2005.06.002 Lachaud, 2000, Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients, J Clin Microbiol, 38, 236, 10.1128/JCM.38.1.236-240.2000 Gatti, 2004, Diagnosis of visceral leishmaniasis: the sensitivities and specificities of traditional methods and a nested PCR assay, Ann Trop Med Parasitol, 7, 667, 10.1179/000349804225011488 Fernandez-Guerrero, 2004, Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis, Acta Trop, 90, 11, 10.1016/j.actatropica.2003.09.009 Ivanovski, 2005, Living-unrelated (paid) renal transplantation: ten years later, Transplant Proc, 37, 563, 10.1016/j.transproceed.2004.12.139 Olivier, 2005, Subversion mechanisms by which leishmania parasites can escape the host immune response: a signaling point of view, Clin Microbiol Rev, 18, 293, 10.1128/CMR.18.2.293-305.2005 Scharton-Kersten, 1995, IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis, J Immunol, 154, 5320, 10.4049/jimmunol.154.10.5320 Molina, 2002, HIV and the transmission of Leishmania, Ann Trop Med Parasitol, 97, S29 Offermann, 2004, Immunosuppression for long term maintenance of renal allograft function, Drugs, 64, 1325, 10.2165/00003495-200464120-00005 Lopez-Velez, 1998, Clinico-epidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and leishmania in an area of Madrid, Am J Trop Med Hyg, 58, 436, 10.4269/ajtmh.1998.58.436 Cascio, 2002, Pediatric visceral leishmaniasis in western Sicily, Italy: a retrospective analysis of 111 cases, Eur J Clin Microbiol Infect Dis, 21, 277, 10.1007/s10096-002-0707-3 Pasquau, 2005, Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterranean region, Eur J Clin Microbiol Infect Dis, 24, 1342, 10.1007/s10096-005-1342-6 Caldas, 2006, Are differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?, Acta Trop, 97, 252, 10.1016/j.actatropica.2005.09.010 Pratlong, 2002, Enzymatic polymorphism during leishmania/HIV coinfection: a study of 381 leishmania strains received between 1986 and 2000 at the international cryobank in Montpellier, France, Ann Trop Med Parasitol, 97, S47 Ridolfo, 2000, Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patients infected with Leishmania infantum, J Infect, 40, 199, 10.1053/jinf.1999.0630 Casolari, 2005, A rare case of localized mucosal leishmaniasis due to Leishmania infantum in a immunocompetent italian host, Eur J Epidemiol, 20, 559, 10.1007/s10654-005-1249-7 Green, 2004, Guidelines for the prevention and management of infectious complications of solid organ transplantation, Am J Transplant, 4, 142 Goodwin, 1995, Pentostam (sodium stibogluconate): a 50 year personal reminescence, Trans R Soc Trop Med Hyg, 89, 339, 10.1016/0035-9203(95)90572-3 Buffet, 1995, Tolerance and pharmacokinetics of antimony in a patient with renal failure, Nephrol Dial Transplant, 10, 1477 Murray, 2004, Progress in the treatment of a neglected infectious disease: visceral leishmaniasis, Expert Rev Anti Infect Ther, 2, 279, 10.1586/14787210.2.2.279 Meyerhoff, 1999, US Food and Drug Administration approval of Ambisome (liposomal amphotericin B) for treatment of visceral leishmaniasis, Clin Infect Dis, 28, 42, 10.1086/515085 Berman, 1999, US Food and Drug Administration approval of Ambisome (liposomal amphotericin B) for treatment of visceral leishmaniasis, Clin Infect Dis, 28, 49, 10.1086/515086 Gradoni, 2003, Visceral leishmaniasis treatment in Italy, Emerg Infect Dis, 9, 1617, 10.3201/eid0912.030178 Bern, 2006, Liposomal amphotericin B for the treatment of visceral leishmaniasis, Clin Infect Dis, 43, 917, 10.1086/507530 Ringden, 1994, Safety of liposomal amphotericin B (Ambisome) in 187 transplant recipients treated with cyclosporine, Bone Marrow Transplant, 14, S10 Soto, 2006, Miltefosine: oral treatment of leishmaniasis, Expert Rev Anti Infect Ther, 4, 177, 10.1586/14787210.4.2.177 Ghosh, 1995, Visceral leishmaniasis in kidney transplant recipients. An endemic disease, Transplantation, 59, 453 Ribera, 1996, Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients, Am J Med, 100, 406, 10.1016/S0002-9343(97)89503-4 Orlando, 1998, Secondary prophylaxis for leishmania infection in an HIV-positive patient, AIDS, 12, 2086, 10.1097/00002030-199815000-00029 Angarano, 1998, Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients, Eur J Clin Microbiol Infect Dis, 17, 365, 10.1007/BF01709465